The changes in bone turnover markers of female systemic lupus erythematousus patients without glucocorticoid

Abstract

Objectives SLE is a chronic autoimmune disease, which can affect the level of bone metabolism and increase the risk of osteoporosis and fracture. The purpose of this research is to study the effect of SLE on bone turnover markers without the influence of glucocorticoids. Methods A total of 865 female subjects were recruited from Zhejiang Provincial People’s Hospital and the First Hospital of Jiaxing, including 391 SLE patients without the influence of glucocorticoids and 474 non-SLE people. We detected Bone turnover markers including amino-terminal propeptide of type 1 procollagen (P1NP), C-terminal turnover of β - I collagen (β-CTX), N-terminal midfragment of osteocalcin (NMID) and 25(OH)D, and analyzed the difference in Bone turnover markers between the SLE group and the control group, as well as the influence of age and season on bone metabolism in female SLE patients. Results In the SLE group, the average age was 43.93±13.95\u2009years old. In the control group, the average age was 44.84±11.42\u2009years old. There was no difference between the two groups (t\u2009=\u20091.03, P\u2009=\u20090.30). P1NP, NMID and 25(OH)D in the SLE group were significantly lower than those in the control group (Z\u2009=\u20098.44, p\u2009<\u20090.001; Z\u2009=\u200914.41, p\u2009<\u20090.001; Z\u2009=\u20092.19, p\u2009=\u20090.029), and β-CTX in the SLE group was significantly higher than that in the control group (Z\u2009=\u20092.61, p\u2009=\u20090.009). In addition, the levers of β-CTX, NMID, P1NP and 25(OH)D in older SLE female patients were statistically significantly higher than those in younger (ρ\u2009=\u20090.104, p\u2009=\u20090.041; ρ\u2009=\u20090.223, p\u2009<\u20090.001; ρ\u2009=\u20090.105, p\u2009=\u20090.038; ρ\u2009=\u20090.289, p\u2009<\u20090.001). Moreover, β-CTX reached a high value in summer and PINP reached a low value in winter. Conclusion The bone formation markers of female SLE patients without glucocorticoid were lower than those of normal people and the bone resorption marker was higher than that of normal people. The 25 (OH) D of female SLE patients without glucocorticoid was lower than that of normal people. The risk of osteoporosis and fracture may be higher in elderly women with SLE. The bone resorption level of female SLE patients is high in summer and the bone formation level is low in winter.